Cell-free tumour DNA in bronchoalveolar lavage: a proof of concept study
Open Access
- 26 February 2026
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
Abstract
Extract Molecular analysis is increasingly integral to lung cancer evaluation and management [1]. While evidence of circulating tumor DNA (ctDNA) has existed for decades [2], research in this field centers on ctDNA detection primarily in peripheral blood, which may present limitations. These include reduced sensitivity [3, 4], the potential of false negatives due to low tumor burden or shedding [5], and the possibility that lung compartmentalization may prevent cancer cells from appearing in systematic circulation [6]. We hypothesized that bronchoalveolar lavage (BAL) would exhibit an enrichment of lung cancer-derived cell-free DNA (cfDNA) detectable using digital PCR (dPCR), a precise method for nucleic acid quantification.Keywords
Funding Information
- Juravinski Hospital and Cancer Care Foundation (3576.5024012)
- Community Health and Education Research Fund of the Hamilton Community Foundation (7738200922)
- Hamilton Academic Health Sciences Organization (7738200808,)
- Medical Surgical Association Fund (20018864)
This publication has 13 references indexed in Scilit:
- Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor TissueJCO Precision Oncology, 2025
- Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for genome profiling in advanced non-small cell lung cancerLung Cancer, 2025
- Evaluating personalized circulating tumor DNA detection for early‐stage lung cancerCancer Medicine, 2023
- Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung CancerCancer Research, 2022
- Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancerAnnals of Oncology, 2022
- The Diagnostic Accuracy of Liquid Biopsy in EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of 40 StudiesSLAS Technology, 2021
- Personalized Medicine: Recent Progress in Cancer TherapyCancers, 2021
- Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDSCritical Care, 2021
- A comparison of QuantStudio™ 3D Digital PCR and ARMS-PCR for measuring plasma EGFR T790M mutations of NSCLC patientsCancer Management and Research, 2018
- Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical ReviewJournal of Thoracic Oncology, 2017